National Institutes of Health COVID-19 Interest Group Seminar Series

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

Kizzmekia Corbett, Ph.D., NIH NIAID

to be available at videocast.nih.gov